Blydt-Hansen, I., Bech, M. and Jackson, S. (2025) “Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program”, Journal of Hematology, 14(5), pp. 257–261. doi:10.14740/jh2113.